However, in the absence of obesity or diet-induced hepatic lipogenesis, liver-derived LBP appeared to have a protective function, helping to prevent liver inflammation, oxidative stress, and fibrosis, which suggests that inhibiting LBP could potentially amplify the proinflammatory effects of LPS [20,35]. The gene discussed is LBP; the disease is obesity due to melanocortin 4 receptor deficiency.